GeneDx Holdings Correlations
WGSWW Stock | 0.21 0.03 12.50% |
The current 90-days correlation between GeneDx Holdings Corp and GeneDx Holdings Corp is -0.08 (i.e., Good diversification). The correlation of GeneDx Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
GeneDx Holdings Correlation With Market
Good diversification
The correlation between GeneDx Holdings Corp and DJI is -0.15 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding GeneDx Holdings Corp and DJI in the same portfolio, assuming nothing else is changed.
GeneDx |
Moving together with GeneDx Stock
0.73 | ACONW | Aclarion | PairCorr |
0.7 | LUCD | Lucid Diagnostics | PairCorr |
0.61 | LUNG | Pulmonx Corp Downward Rally | PairCorr |
0.75 | AZN | AstraZeneca PLC ADR | PairCorr |
0.63 | GSK | GlaxoSmithKline PLC ADR | PairCorr |
0.64 | LLY | Eli Lilly | PairCorr |
0.71 | NVS | Novartis AG ADR | PairCorr |
0.67 | PLX | Protalix Biotherapeutics | PairCorr |
0.75 | SNY | Sanofi ADR | PairCorr |
0.72 | GILD | Gilead Sciences Sell-off Trend | PairCorr |
0.69 | GOSS | Gossamer Bio | PairCorr |
Moving against GeneDx Stock
0.72 | VINC | Vincerx Pharma Earnings Call This Week | PairCorr |
0.71 | VRDN | Viridian Therapeutics | PairCorr |
0.65 | HOLX | Hologic | PairCorr |
0.64 | SSKN | STRATA Skin Sciences Earnings Call Tomorrow | PairCorr |
0.64 | ELVN | Enliven Therapeutics | PairCorr |
0.62 | CDIOW | Cardio Diagnostics | PairCorr |
0.53 | TELA | Tela Bio | PairCorr |
0.49 | INFU | InfuSystems Holdings | PairCorr |
0.81 | MLTX | MoonLake Immunotherapeuti | PairCorr |
0.78 | ZURA | Zura Bio Limited | PairCorr |
0.71 | IMMX | Immix Biopharma | PairCorr |
0.69 | PYXS | Pyxis Oncology | PairCorr |
0.68 | GPCR | Structure Therapeutics | PairCorr |
0.62 | PMVP | Pmv Pharmaceuticals | PairCorr |
0.52 | IMRX | Immuneering Corp | PairCorr |
0.48 | MRK | Merck Company | PairCorr |
0.43 | INBX | Inhibrx Symbol Change | PairCorr |
0.33 | PHIO | Phio Pharmaceuticals Corp Earnings Call This Week | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between GeneDx Stock performing well and GeneDx Holdings Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze GeneDx Holdings' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
WGS | 5.15 | 0.92 | 0.15 | 0.34 | 5.09 | 10.24 | 56.43 | |||
ICUCW | 8.49 | 1.47 | 0.12 | 0.72 | 10.01 | 18.33 | 73.84 | |||
HUMAW | 5.56 | (0.29) | 0.00 | (0.32) | 0.00 | 12.26 | 51.58 | |||
SHCRW | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
SLGCW | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
GeneDx Holdings Corporate Management
Daniel JD | Secretary | Profile | |
Heidi JD | Chief Officer | Profile | |
Britt Johnson | Head Affairs | Profile | |
Jami Biliboaca | Head Strategy | Profile | |
Eric Olivares | Chief Officer | Profile | |
Tricia Truehart | Head Relations | Profile |